Voyager Therapeutics, Inc. (VYGR): Price and Financial Metrics


Voyager Therapeutics, Inc. (VYGR): $3.88

0.09 (+2.37%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

VYGR POWR Grades


  • VYGR scores best on the Value dimension, with a Value rank ahead of 87.31% of US stocks.
  • VYGR's strongest trending metric is Growth; it's been moving down over the last 52 weeks.
  • VYGR ranks lowest in Growth; there it ranks in the 0th percentile.

VYGR Stock Summary

  • Of note is the ratio of Voyager Therapeutics Inc's sales and general administrative expense to its total operating expenses; only 14.49% of US stocks have a lower such ratio.
  • The ratio of debt to operating expenses for Voyager Therapeutics Inc is higher than it is for about merely 0.4% of US stocks.
  • In terms of volatility of its share price, VYGR is more volatile than 91.64% of stocks we're observing.
  • If you're looking for stocks that are quantitatively similar to Voyager Therapeutics Inc, a group of peers worth examining would be MRUS, MTEM, CTMX, CRUS, and GLYC.
  • Visit VYGR's SEC page to see the company's official filings. To visit the company's web site, go to www.voyagertherapeutics.com.

VYGR Valuation Summary

  • VYGR's EV/EBIT ratio is 0.3; this is 98.98% lower than that of the median Healthcare stock.
  • VYGR's price/earnings ratio has moved up 23.7 over the prior 71 months.
  • VYGR's price/earnings ratio has moved up 23.7 over the prior 71 months.

Below are key valuation metrics over time for VYGR.

Stock Date P/S P/B P/E EV/EBIT
VYGR 2021-08-31 0.9 1.1 6.9 0.3
VYGR 2021-08-30 0.9 1.1 6.8 0.2
VYGR 2021-08-27 0.9 1.1 6.5 -0.1
VYGR 2021-08-26 0.9 1.1 6.7 0.1
VYGR 2021-08-25 0.9 1.1 6.9 0.3
VYGR 2021-08-24 0.9 1.1 6.8 0.2

VYGR's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • VYGR has a Quality Grade of D, ranking ahead of 17.09% of graded US stocks.
  • VYGR's asset turnover comes in at 0.541 -- ranking 75th of 681 Pharmaceutical Products stocks.
  • MDVL, RDUS, and CPHI are the stocks whose asset turnover ratios are most correlated with VYGR.

The table below shows VYGR's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.541 1 0.193
2021-03-31 0.598 1 0.402
2020-12-31 0.595 1 0.386
2020-09-30 0.634 1 0.362
2020-06-30 0.296 1 -0.420
2020-03-31 0.325 1 -0.223

VYGR Price Target

For more insight on analysts targets of VYGR, see our VYGR price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $7.06 Average Broker Recommendation 1.8 (Moderate Buy)

VYGR Stock Price Chart Interactive Chart >

Price chart for VYGR

VYGR Price/Volume Stats

Current price $3.88 52-week high $12.00
Prev. close $3.79 52-week low $2.46
Day low $3.73 Volume 1,457,900
Day high $3.92 Avg. volume 2,055,718
50-day MA $3.41 Dividend yield N/A
200-day MA $4.69 Market Cap 147.19M

Voyager Therapeutics, Inc. (VYGR) Company Bio


Voyager Therapeutics, Inc., a clinical-stage gene therapy company, focuses on the development of treatments for patients suffering from severe diseases of the central nervous system. The company was founded in 2013 and is based in Cambridge, Massachusetts.


VYGR Latest News Stream


Event/Time News Detail
Loading, please wait...

VYGR Latest Social Stream


Loading social stream, please wait...

View Full VYGR Social Stream

Latest VYGR News From Around the Web

Below are the latest news stories about Voyager Therapeutics Inc that investors may wish to consider to help them evaluate VYGR as an investment opportunity.

Voyager Therapeutics Presents Positive Preclinical Data Supporting CNS-Directed GBA1 Gene Therapy at Virtual Congress of the European Society of Gene and Cell Therapy

Single AAV intravenous dose achieved widespread CNS distribution and sustained correction of GCase activity in multiple brain regionsCAMBRIDGE, Mass., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a gene therapy company developing life-changing treatments and next-generation adeno-associated virus (AAV) platform technologies, today announced the presentation of preclinical data demonstrating a single intravenous (IV) dose of its novel GBA1 gene replacement therapy

Yahoo | October 20, 2021

Is Voyager Therapeutics, Inc. (NASDAQ:VYGR) Popular Amongst Institutions?

If you want to know who really controls Voyager Therapeutics, Inc. ( NASDAQ:VYGR ), then you'll have to look at the...

Yahoo | October 14, 2021

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Good morning, investor!

William White on InvestorPlace | October 12, 2021

Is Voyager Stock a Buy Following Pfizer Deal? This Is What You Need to Know

The risk averse are likely to mostly stay away from the highly volatile biotech sector but for those ready to embrace the danger, there can be ample rewards. Just ask Voyager (VYGR) investors following Wednesday’s action. Shares gained 57% in the session after the micro-cap announced a deal with Pfizer that, in total, could be worth $630 million. Voyager entered into a License Option Agreement with the pharma giant for the potential use of two novel capsids generated from Voyager’s RNA-driven TRACER platform, one for the treatment of a neurological disorder and the second for a cardiovascular disease.

Marty Shtrubel on TipRanks | October 7, 2021

Voyager (VYGR) Surges on Gene Therapy Deal With Pfizer

Voyager (VYGR) signs agreement with Pfizer granting the latter with rights to develop novel capsids using Voyager's proprietary technology for Pfizer's gene therapies and options for exclusive license to the capsids.

Yahoo | October 7, 2021

Read More 'VYGR' Stories Here

VYGR Price Returns

1-mo 31.97%
3-mo 20.12%
6-mo -21.14%
1-year -64.89%
3-year -72.27%
5-year -67.80%
YTD -45.73%
2020 -48.75%
2019 48.40%
2018 -43.37%
2017 30.30%
2016 -41.83%

Continue Researching VYGR

Here are a few links from around the web to help you further your research on Voyager Therapeutics Inc's stock as an investment opportunity:

Voyager Therapeutics Inc (VYGR) Stock Price | Nasdaq
Voyager Therapeutics Inc (VYGR) Stock Quote, History and News - Yahoo Finance
Voyager Therapeutics Inc (VYGR) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.845 seconds.